Depression screening tools in persons with epilepsy: A systematic review of validated tools

被引:115
|
作者
Gill, Stephanie J. [1 ,2 ]
Lukmanji, Sara [1 ,2 ]
Fiest, Kirsten M. [2 ,3 ,4 ,5 ]
Patten, Scott B. [2 ,3 ,4 ,6 ,7 ]
Wiebe, Samuel [1 ,2 ,3 ,4 ]
Jette, Nathalie [1 ,2 ,3 ,4 ]
机构
[1] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[2] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
[4] Univ Calgary, OBrien Inst Publ Hlth, Calgary, AB, Canada
[5] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada
[6] Univ Calgary, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB, Canada
[7] Univ Calgary, Dept Psychiat, Calgary, AB, Canada
关键词
Major depressive disorder; Mental health; Comorbidity; Diagnostic accuracy; Measurement; PATIENT HEALTH QUESTIONNAIRE-2; MAJOR DEPRESSION; HOSPITAL ANXIETY; NDDI-E; CHINESE VERSION; SPANISH VERSION; RAPID DETECTION; GERMAN VERSION; RATING-SCALE; PRIMARY-CARE;
D O I
10.1111/epi.13651
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: Depression affects approximately 25% of epilepsy patients. However, the optimal tool to screen for depression in epilepsy has not been definitively established. The purpose of this study was to systematically review the literature on the validity of depression-screening tools in epilepsy. Methods: MEDLINE, EMBASE, and PsycINFO were searched until April 4, 2016 with no restriction on dates. Abstract, full-text review and data abstraction were conducted in duplicate. We included studies that evaluated the validity of depression-screening tools and reported measures of diagnostic accuracy (e.g., sensitivity, specificity, and negative and positive predictive values) in epilepsy. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies Version 2. Medians and ranges for estimates of diagnostic accuracy were calculated when appropriate. Results: A total of 16,070 abstracts were screened, and 38 articles met eligibility criteria. Sixteen screening tools were validated in 13 languages. The most commonly validated screening tool was the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) (n=26). The Mini International Neuropsychiatric Interview (MINI) (n=19) was the most common reference standard used. At the most common cutpoint of >15 (n=12 studies), the NDDI-E had a median sensitivity of 80.5% (range 64.0-100.0) and specificity of 86.2 (range 81.0-95.6). Meta-analyses were not possible due to variability in cutpoints assessed, reference standards used, and lack of confidence intervals reported. Significance: A number of studies validated depression screening tools; however, estimates of diagnostic accuracy were inconsistently reported. The validity of scales in practice may have been overestimated, as cutpoints were often selected post hoc based on the study sample. The NDDI-E, which performed well, was the most commonly validated screening tool, is free to the public, and is validated in multiple languages and is easy to administer, although selection of the best tool may vary depending on the setting and available resources.
引用
收藏
页码:695 / 705
页数:11
相关论文
共 50 条
  • [1] Anxiety screening tools in people with epilepsy: A systematic review of validated tools
    Wang, Zilin
    Luo, Zhiwen
    Li, Shunhua
    EPILEPSY & BEHAVIOR, 2019, 99
  • [2] Validating screening tools for depression in epilepsy
    Fiest, Kirsten M.
    Patten, Scott B.
    Wiebe, Samuel
    Bulloch, Andrew G. M.
    Maxwell, Colleen J.
    Jette, Nathalie
    EPILEPSIA, 2014, 55 (10) : 1642 - 1650
  • [3] Validated screening tools for the assessment of cachexia, sarcopenia, and malnutrition: a systematic review
    Miller, Janice
    Wells, Liz
    Nwulu, Ugochinyere
    Currow, David
    Johnson, Miriam J.
    Skipworth, Richard J. E.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2018, 108 (06): : 1196 - 1208
  • [4] Nutritional Screening Tools Used and Validated for Cancer Patients: A Systematic Review
    Mendes, Nelia Pinheiro
    de Barros, Thalita Alves
    Barbosa Rosa, Carla de Oliveira
    Castro Franceschini, Sylvia do Carmo
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2019, 71 (06): : 898 - 907
  • [5] Delirium screening tools validated in the context of palliative care: A systematic review
    Watt, Christine L.
    Scott, Mary
    Webber, Colleen
    Sikora, Lindsey
    Bush, Shirley H.
    Kabir, Monisha
    Boland, Jason W.
    Woodhouse, Rebecca
    Sands, Megan B.
    Lawlor, Peter G.
    PALLIATIVE MEDICINE, 2021, 35 (04) : 683 - 696
  • [6] Validated Tools for Screening Sarcopenia: A Scoping Review
    Lian, Rongna
    Jiang, Gengchen
    Liu, Qianqian
    Shi, Qiling
    Luo, Shuyue
    Lu, Jing
    Yang, Ming
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2023, 24 (11) : 1645 - 1654
  • [7] Depression Screening Tools for Patients with Kidney Failure A Systematic Review
    Kondo, Karli
    Antick, Jennifer R.
    Ayers, Chelsea K.
    Kansagara, Devan
    Chopra, Pavan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (12): : 1785 - 1795
  • [8] Postpartum Depression Screening Tools: A Review
    Ukatu, Nneamaka
    Clare, Camille A.
    Brulja, Mary
    PSYCHOSOMATICS, 2018, 59 (03) : 211 - 219
  • [9] Postpartum Depression Screening Tools: A Review
    Ukatu, Nneamaka
    Brulja, Maria
    Clare, Camille A.
    JOURNAL OF WOMENS HEALTH, 2019, 28 (06) : 10 - 10
  • [10] Methodological challenges in using screening tools for depression in migraine: A systematic review
    Asheer, Jasmin
    Ali, Fatima
    Hilker, Rikke
    Videbech, Poul
    Schytz, Henrik Winther
    CEPHALALGIA, 2025, 45 (02)